Kenya confirms ninth Ebola case amid concerns about regional spread | Ebola News
Kenya Reports New Ebola Case Amid Growing Concerns of Regional Spread
Kenya’s Ministry of Health announced today that a 24-year-old man in quarantine has tested positive for Ebola, increasing the country’s total number of confirmed cases to nine. This case contributes to a broader outbreak in the Democratic Republic of Congo (DRC), prompting fears of further transmission in the region.
The patient was isolated at the onset of symptoms and began treatment immediately following the confirmation of his positive test. According to health officials, he was already under quarantine when he developed illness.
This latest case is linked to Kenya’s first Ebola patient, who traveled from the DRC to Uganda before arriving in Kenya. That individual died on October 5 at a hospital in Nairobi.
“All nine cases belong to one cluster, and as of today, there is no evidence of transmission outside this group,” said Patrick Amoth, the Director-General for Health. He reported that eight of the patients are stable and responding well to treatment. Health authorities have successfully traced and quarantined 134 of 135 identified contacts.
Amoth indicated that many contacts could soon safely return home as they have remained symptom-free for the requisite 21-day monitoring period. Health officials urged communities to welcome them back, emphasizing that they do not pose a risk of infection.
The Ministry of Health confirmed that no new infections have been reported within quarantine facilities. Continuous monitoring of infection prevention measures is being conducted to protect health workers.
Despite the Nairobi outbreak, Kenyan authorities have not imposed restrictions on travel, trade, or public gatherings, asserting that the country remains open for business.
The ongoing outbreak in the DRC has seen over 9,000 reported cases and more than 4,000 fatalities since May, marking it as the second-largest Ebola epidemic on record. Containing the outbreak has been challenging due to the absence of a licensed vaccine or specific treatments for the Bundibugyo strain of the virus.
